Varex Imaging Stock Forecast, Price & News

-0.58 (-1.97 %)
(As of 09/17/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume1.79 million shs
Average Volume299,231 shs
Market Capitalization$1.14 billion
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive VREX News and Ratings via Email

Sign-up to receive the latest news and ratings for Varex Imaging and its competitors with MarketBeat's FREE daily newsletter.

Varex Imaging logo

About Varex Imaging

Varex Imaging Corp. engages in the design, manufacture, and sale of imaging components. It operates through the Medical and Industrial segments. The Medical segment delivers and services x-ray imaging components, including X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, and three-dimensional reconstruction software. The Industrial segment offers x-ray imaging products for use in security, and nondestructive testing and inspection applications. The company was founded in July 2016 and is headquartered in Salt Lake City, UT.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.23 out of 5 stars

Medical Sector

1147th out of 1,350 stocks

Electronic Components, Not Elsewhere Classified Industry

9th out of 11 stocks

Analyst Opinion: 1.3Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Varex Imaging (NASDAQ:VREX) Frequently Asked Questions

Is Varex Imaging a buy right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Varex Imaging in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Varex Imaging stock.
View analyst ratings for Varex Imaging
or view top-rated stocks.

What stocks does MarketBeat like better than Varex Imaging?

Wall Street analysts have given Varex Imaging a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Varex Imaging wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Varex Imaging's next earnings date?

Varex Imaging is scheduled to release its next quarterly earnings announcement on Tuesday, November 16th 2021.
View our earnings forecast for Varex Imaging

How were Varex Imaging's earnings last quarter?

Varex Imaging Co. (NASDAQ:VREX) announced its quarterly earnings data on Tuesday, August, 3rd. The company reported $0.40 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.27 by $0.13. The firm had revenue of $211.20 million for the quarter, compared to analyst estimates of $205.15 million. Varex Imaging had a negative net margin of 2.22% and a positive trailing twelve-month return on equity of 6.75%.
View Varex Imaging's earnings history

How has Varex Imaging's stock price been impacted by Coronavirus?

Varex Imaging's stock was trading at $22.13 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, VREX stock has increased by 30.7% and is now trading at $28.92.
View which stocks have been most impacted by COVID-19

What guidance has Varex Imaging issued on next quarter's earnings?

Varex Imaging issued an update on its fourth quarter 2021 earnings guidance on Tuesday, August, 17th. The company provided earnings per share guidance of $0.250-$0.400 for the period, compared to the Thomson Reuters consensus estimate of $0.300. The company issued revenue guidance of $205 million-$225 million, compared to the consensus revenue estimate of $202.27 million.

What price target have analysts set for VREX?

2 brokerages have issued 1-year target prices for Varex Imaging's shares. Their forecasts range from $14.00 to $41.00. On average, they anticipate Varex Imaging's share price to reach $27.50 in the next twelve months. This suggests that the stock has a possible downside of 4.9%.
View analysts' price targets for Varex Imaging
or view top-rated stocks among Wall Street analysts.

Who are Varex Imaging's key executives?

Varex Imaging's management team includes the following people:
  • Sunny S. Sanyal, President, Chief Executive Officer & Director
  • David Frick, Vice President-Operations
  • Sam Maheshwari, Chief Financial & Accounting Officer
  • Victor Garcia, Vice President-Regulatory & Quality Compliance
  • Kimberley E. Honeysett, Secretary, Senior VP & General Counsel

Who are some of Varex Imaging's key competitors?

What other stocks do shareholders of Varex Imaging own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Varex Imaging investors own include Gilead Sciences (GILD), Pfizer (PFE), Varian Medical Systems (VAR), Verizon Communications (VZ), NVIDIA (NVDA), AT&T (T), AbbVie (ABBV), Bausch Health Companies (BHC), Bank of America (BAC) and International Business Machines (IBM).

What is Varex Imaging's stock symbol?

Varex Imaging trades on the NASDAQ under the ticker symbol "VREX."

Who are Varex Imaging's major shareholders?

Varex Imaging's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (17.20%), Vanguard Group Inc. (10.64%), State Street Corp (5.25%), Wells Fargo & Company MN (4.46%), Dimensional Fund Advisors LP (3.92%) and Cooke & Bieler LP (3.83%). Company insiders that own Varex Imaging stock include Brian W Giambattista, Clarence R Verhoef, Erich R Reinhardt, Kevin Bruce Yankton, Kimberley E Honeysett, Mark S Jonaitis and Ruediger Naumann-Etienne.
View institutional ownership trends for Varex Imaging

Which major investors are selling Varex Imaging stock?

VREX stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Black Creek Investment Management Inc., Pzena Investment Management LLC, BlackRock Inc., Cubist Systematic Strategies LLC, JPMorgan Chase & Co., Bank of New York Mellon Corp, and Citigroup Inc.. Company insiders that have sold Varex Imaging company stock in the last year include Kimberley E Honeysett, and Ruediger Naumann-Etienne.
View insider buying and selling activity for Varex Imaging
or view top insider-selling stocks.

Which major investors are buying Varex Imaging stock?

VREX stock was purchased by a variety of institutional investors in the last quarter, including Artisan Partners Limited Partnership, Frontier Capital Management Co. LLC, State Street Corp, Nuveen Asset Management LLC, Vanguard Group Inc., Bank of Montreal Can, Dimensional Fund Advisors LP, and Knights of Columbus Asset Advisors LLC.
View insider buying and selling activity for Varex Imaging
or or view top insider-buying stocks.

How do I buy shares of Varex Imaging?

Shares of VREX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Varex Imaging's stock price today?

One share of VREX stock can currently be purchased for approximately $28.92.

How much money does Varex Imaging make?

Varex Imaging has a market capitalization of $1.14 billion and generates $738.30 million in revenue each year. The company earns $-57,900,000.00 in net income (profit) each year or $0.08 on an earnings per share basis.

How many employees does Varex Imaging have?

Varex Imaging employs 2,000 workers across the globe.

What is Varex Imaging's official website?

The official website for Varex Imaging is

Where are Varex Imaging's headquarters?

Varex Imaging is headquartered at 1678 SOUTH PIONEER ROAD, SALT LAKE CITY UT, 84104.

How can I contact Varex Imaging?

Varex Imaging's mailing address is 1678 SOUTH PIONEER ROAD, SALT LAKE CITY UT, 84104. The company can be reached via phone at (801) 972-5000 or via email at [email protected].

This page was last updated on 9/18/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.